Evidence map›Paper›PMID 35639952›Full record

ArticleBioinformatics (Oxford, England)2022

Metapone: a Bioconductor package for joint pathway testing for untargeted metabolomics data.

Leqi Tian, Zhenjiang Li, Guoxuan Ma, Xiaoyue Zhang, Ziyin Tang, Siheng Wang, Jian Kang, Donghai Liang, Tianwei Yu

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Prenatal Nitrogen Oxide (NOEnvironmental science & technology · 2025
    Article
  3. Metabolic dysregulation in Alzheimer's disease: A brain metabolomics approach.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Leqi TianShenzhen Research Institute of Big Data, Shenzhen 518712, China.ORCID 0000-0001-6080-4076
Zhenjiang LiGangarosa Department of Environmental Health, Emory University, Atlanta, GA 30322, USA.
Guoxuan MaSchool of Data Science, The Chinese University of Hong Kong - Shenzhen, Shenzhen 518712, China.
Xiaoyue ZhangGangarosa Department of Environmental Health, Emory University, Atlanta, GA 30322, USA.
Ziyin TangGangarosa Department of Environmental Health, Emory University, Atlanta, GA 30322, USA.
Siheng WangSchool of Data Science, The Chinese University of Hong Kong - Shenzhen, Shenzhen 518712, China.
Jian KangDepartment of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA.
Donghai LiangGangarosa Department of Environmental Health, Emory University, Atlanta, GA 30322, USA.
Tianwei YuShenzhen Research Institute of Big Data, Shenzhen 518712, China.

Funding

Pilot Project ProgramP30ES019776 · NIEHS · EMORY UNIVERSITY · PI William Michael Caudle · 2013 to 2026
$22.6M
Bayesian Network Biomarker Selection in Metabolomics DataR01GM124061 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KANG, JIAN · 2017 to 2020
$1.4M
Traffic Exposure, Maternal Metabolome and Birth Outcomes Study (TEMMBO Study)R21ES032117 · NIEHS · EMORY UNIVERSITY · PI LIANG, DONGHAI · 2021 to 2022
$420k
NIEHS NIH HHS P30 ES019776NIEHS NIH HHS R21 ES032117NIGMS NIH HHS R01 GM124061Shenzhen Research Institute of Big DataUniversity Development Fund of CUHK-Shenzhen
6 · The paper itself

Abstract

motivationTesting for pathway enrichment is an important aspect in the analysis of untargeted metabolomics data. Due to the unique characteristics of untargeted metabolomics data, some key issues have not been fully addressed in existing pathway testing algorithms: (i) matching uncertainty between data features and metabolites; (ii) lacking of method to analyze positive mode and negative mode liquid chromatography-mass spectrometry (LC/MS) data simultaneously on the same set of subjects; (iii) the incompleteness of pathways in individual software packages.

resultsWe developed an innovative R/Bioconductor package: metabolic pathway testing with positive and negative mode data (metapone), which can perform two novel statistical tests that take matching uncertainty into consideration-(i) a weighted gene set enrichment analysis-type test and (ii) a permutation-based weighted hypergeometric test. The package is capable of combining positive- and negative-ion mode results in a single testing scheme. For comprehensiveness, the built-in pathways were manually curated from three sources: Kyoto Encyclopedia of Genes and Genomes, Mummichog and The Small Molecule Pathway Database. AVAILABILITY AND IMPLEMENTATION: The package is available at https://bioconductor.org/packages/devel/bioc/html/metapone.html. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

MetabolomicsSoftwareAlgorithmsGenomeHumansMetabolic Networks and Pathways

Identifiers

PMID35639952
PMCPMC9272804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.